Insight Folios’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$352K Buy
3,189
+65
+2% +$6.8K 0.13% 90
2024
Q2
$307K Sell
3,124
-79
-2% -$8.05K 0.13% 89
2024
Q1
$358K Sell
3,203
-900
-22% -$97.1K 0.15% 78
2023
Q4
$414K Sell
4,103
-312
-7% -$31K 0.18% 65
2023
Q3
$383K Sell
4,415
-706
-14% -$63.8K 0.19% 64
2023
Q2
$484K Sell
5,121
-400
-7% -$33.8K 0.2% 57
2023
Q1
$417K Sell
5,521
-292
-5% -$22K 0.18% 51
2022
Q4
$447K Buy
5,813
+103
+2% +$7.83K 0.2% 44
2022
Q3
$381K Buy
5,710
+115
+2% +$7.29K 0.19% 47
2022
Q2
$292K Sell
5,595
-72
-1% -$4.09K 0.14% 88
2022
Q1
$321K Buy
5,667
+513
+10% +$27.5K 0.14% 94
2021
Q4
$265K Buy
5,154
+334
+7% +$16.4K 0.12% 121
2021
Q3
$238K Buy
4,820
+744
+18% +$40.4K 0.13% 112
2021
Q2
$233K Buy
+4,076
New +$238K 0.14% 70

Other funds holding CAH

Insight Folios's CAH Position: Q3 2024 in Review

Insight Folios increased its Cardinal Health (CAH) stake by 2.1% in Q3 2024, buying an estimated $6.8K and bringing the position to 3,189 shares worth $352K. The position accounts for 0.13% of the portfolio, ranked #90.

Insight Folios first reported a position in CAH in Q2 2021 and has held it in 14 quarters since. The position peaked at $484K in Q2 2023. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Insight Folios held 3,189 shares of Cardinal Health worth $352K as of Q3 2024.
  • Insight Folios bought 65 Cardinal Health shares in Q3 2024, an estimated $6.8K.
  • Cardinal Health made up 0.13% of Insight Folios's portfolio in Q3 2024, its #90 holding.
  • Insight Folios first reported a position in Cardinal Health in Q2 2021 and has held it in 14 quarters since.
  • Insight Folios's Cardinal Health position peaked at $484K in Q2 2023.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Insight Folios's 13F filing for Q3 2024, filed 24 Oct 2024.